CorMedix Inc. (CRMD) › Total AssetsCorMedix Inc. (CRMD) — Total AssetsAnnual figures by period end, from SEC filings.2010-12-31: $8.85M2011-12-31: $2.56M2012-12-31: $1.15M2013-12-31: $2.97M2014-12-31: $5.10M2015-12-31: $37.10M2016-12-31: $21.91M2017-12-31: $13.45M2018-12-31: $18.83M2019-12-31: $29.48M2020-12-31: $49.31M2021-12-31: $68.95M2022-12-31: $62.04M2023-12-31: $82.06M2024-12-31: $118.85M2025-12-31: $826.14M$826.14M2010-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$826.14M+595.1%2026-03-05Balance as of period end2024-12-31$118.85M+44.8%2026-03-05Balance as of period end2023-12-31$82.06M+32.3%2025-03-25Balance as of period end2022-12-31$62.04M-10.0%2024-03-12Balance as of period end2021-12-31$68.95M+39.8%2023-03-30Balance as of period end2020-12-31$49.31M+67.3%2022-03-29Balance as of period end2019-12-31$29.48M+56.6%2021-03-30Balance as of period end2018-12-31$18.83M+39.9%2020-03-16Balance as of period end2017-12-31$13.45M-38.6%2019-05-29Balance as of period end2016-12-31$21.91M-41.0%2018-03-19Balance as of period end2015-12-31$37.10M+627.8%2017-03-16Balance as of period end2014-12-31$5.10M+71.8%2016-03-15Balance as of period end2013-12-31$2.97M+157.3%2015-03-12Balance as of period end2012-12-31$1.15M-54.9%2014-03-31Balance as of period end2011-12-31$2.56M-71.1%2014-03-04Balance as of period end2010-12-31$8.85M—2012-04-26Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)